ReviewBMC infectious diseases2019
Roseomonas mucosa infective endocarditis in patient with systemic lupus erythematosus: case report and review of literature.
Review in BMC infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 25 citations in OpenAlex.
- Phenotypic and genomic characterization ofAntimicrobial agents and chemotherapy · 2026Article
- Comparison of three routine methods for the identification ofFrontiers in microbiology · 2026Article
- Roseomonas populi sp. nov., an acetate-degrading bacteria isolated from the stem of Populus tomentosa.Antonie van Leeuwenhoek · 2023Article
- Cellulitis caused by Roseomonas mucosa in a child: a case report.BMC infectious diseases · 2023Article
- Roseomonas Species Bacteremia With Associated Endocarditis and Possible CNS Septic Embolic Phenomenon.Cureus · 2023Article
- Infective Spondylitis with Epidural Abscess Formation Caused byCase reports in infectious diseases · 2023Article
- Lactobacillus spp. in the reproductive system of female moths and mating induced changes and possible transmission.BMC microbiology · 2022Article
- Nasal Dysbiosis in Cutaneous T-Cell Lymphoma Is Characterized by Shifts in Relative Abundances of Non-JID innovations : skin science from molecules to population health · 2022Article
- Differences between the effects of plant species and compartments on microbiome composition in two halophyteBioengineered · 2022Article
- Cardiac tamponade due to perforation of aBMJ case reports · 2022Article
- Isolation and characterization of tick-borne Roseomonas haemaphysalidis sp. nov. and rodent-borne Roseomonas marmotae sp. nov.Journal of microbiology (Seoul, Korea) · 2022Article
- Biofilm growth and microbial contamination of dental unit waterlines at Kuwait University dental center.Frontiers in oral health · 2022Article
- A Journey on the Skin Microbiome: Pitfalls and Opportunities.International journal of molecular sciences · 2021Review
- Phylotaxogenomics for the Reappraisal of the GenusFrontiers in microbiology · 2021Article
- The Skin Microbiota: Balancing Risk and Reward.Cell host & microbe · 2020Review
- Chronic suppurative otitis media due to Streptomyces cacaoi, the second case report in human infection.BMC infectious diseases · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRoseomonas mucosa, as a Gram-negative coccobacilli, is an opportunistic pathogen that has rarely been reported in human infections. Here we describe a case of bacteremia in an infective endocarditis patient with systemic lupus erythematosus (SLE). CASE PRESENTATIONS: A 44-year-old female patient with SLE suffered bacteremia caused by Roseomonas mucosa complicated with infective endocarditis (IE). The patient started on treatment with piperacillin-tazobactam and levofloxacin against Roseomonas mucosa, which was switched after 4 days to meropenem and amikacin for an additional 2 weeks. She had a favorable outcome with a 6-week course of intravenous antibiotic therapy. DISCUSSION AND
conclusionsRoseomonas mucosa is rarely reported in IE patients; therefore, we report the case in order to improve our ability to identify this pathogen and expand the range of known bacterial causes of infective endocarditis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.